Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > About to KABOOM on both US and Canada sides

<< Previous

Bullboard Posts

Next >>

Comment by O12009on Jan 17, 2023 5:17pm

304 Views

Post# 35229258

RE:RE:RE:RE:RE:RE:RE:About to KABOOM on both US and Canada sides

We have had many discussions on the buyout numbers over the years. Back in the day before the vaccine news it was decided that the buyout could be 8 billion US dollars for our ACT. That would make the share price at 26.60 US dollars. So $36 Canadian

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition